VIS171

· Otsuka Pharmaceutical Development & Commercialization, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for VIS171, covering 2025-09-17 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety, PK and PD of VIS171 in Participants (Healthy and With Autoimmune Disease) [Phase 1]

See pricing